Vildagliptin / Galvus / Galvumet) would have to be ceased when GLP-1 agonist is initiated
Nausea, vomiting, and diarrhea were most often reported during periods of dose escalation
GLP ones may have benefits for cardiovascular disease, for, uh, metabolic disease
Many research frameworks pause MT-2 in winter or during long breaks from UV exposure, then re-load before the next sunny window
Choosing Between Semaglutide, Tirzepatide, and Dual-Compound Options Semaglutide injection (at $189/mo month-to-month, or from $149/mo on the 6-month plan) and tirzepatide injection (starting at $289/mo (or $249/mo on the 6-month plan)) both demonstrate strong efficacy in randomized trials, but tirzepatidea dual GLP-1 and GIP receptor agonistproduces slightly greater weight loss on average
4 Diabetes and Complications, Lilly Research Laboratories, Lilly, Indianapolis, Indiana, USA